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Background: Inhalational anesthesia and total intravenous
anesthesia (TIVA) are techniques used for maintenance
of general anesthesia for endoscopic sinus surgery (ESS).
Growing evidence exists that TIVA may be associated with
decreased bleeding and improved surgical fields, yet data
suggest it is used in a minority of sinus surgery cases. The
objective of this study was to investigate perceptions and
approaches to anesthetic maintenance techniques in ESS
among anesthesia providers.
Methods: A total of 719 anesthesiology residents, faculty,
and certified registered nurse anesthetists (CRNAs) at 3
tertiary academic centers in the United States were invited
to participate in a survey of considerations and practice
paerns for inhalational anesthesia and TIVA for ESS.
Results: Responses were received from 200 participants
(28%). Sixty-five percent of respondents reported a lack of
familiarity with current literature on TIVA for ESS. Many
considered factors other than surgical field visualization
when choosing a maintenance technique. Most were com-
fortable with performing TIVA but stated they would par-
ticipate in additional training.
Conclusion: The majority of anesthesiology providers were
unaware of the existing literature demonstrating advantage
in improved surgical visualization with TIVA. Many used
a combination of inhaled and intravenous anesthetics for
maintenance. These findings suggest that future opportu-
nities may exist to develop education, training, and prac-
tice approaches specific to anesthetic techniques for ESS.
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E ndoscopic sinus surgery (ESS) is commonly performedfor various sinonasal pathologies with an estimated
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250,000 cases performed annually in the United States.1
The variability and complexity of the nasal sinuses com-
bined with the close proximity of important anatom-
ical structures such as the brain, orbit, and carotid
arteries leads to risk of major complications includ-
ing cerebrospinal fluid (CSF) leak, orbital injury, and
hemorrhage.2
Significant intraoperative mucosal bleeding interferes
with the surgical visual field and may increase risk of
complications.3,4 Interventions that may improve the sur-
gical field by means of limiting bleeding include intranasal
vasoconstrictor application and injection, preoperative
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steroids, topical decongestants, reverse Trendelenburg po-
sitioning, and controlled hypotension.5,6
Anesthetic technique may influence bleeding risk. Inhala-
tional anesthesia—the maintenance of anesthesia via use
of volatile anesthetics including most commonly sevoflu-
rane, isoflurane, desflurane, and/or nitrous oxide—is asso-
ciated with decreased peripheral vascular resistance, which
may increase bleeding in the nasal mucosa during ESS.7
An alternative technique is total intravenous anesthesia
(TIVA) where anesthetic drugs, most commonly propofol
and remifentanil, are administered intravenously and may
decrease nasal bleeding by limiting peripheral vasodilation
in the nasal mucosa.8 Prior investigation has suggested that
TIVA for ESS can improve surgical field visualization and
bleeding compared to inhalational anesthesia.4,7,9 An addi-
tional advantage of TIVA is the reduced incidence of post-
operative nausea and vomiting (PONV), which may in turn
decrease the risk of postoperative epistaxis.10,11 Despite
these advantages, existing data suggest TIVA is used for as
low as 7% of ESS cases in some locations.12
Although studies have investigated patient outcomes be-
tween inhalational and intravenous techniques, there is
limited information regarding clinician factors in decision-
making that affect anesthetic maintenance approach for
ESS. Therefore, we aimed to provide unique insights into
current ESS anesthetic practices and education via online
questionnaire of anesthesiology residents, faculty, and cer-
tified registered nurse anesthetists (CRNAs). We hypoth-
esized that many anesthesiology providers are not aware
of literature supporting possible improved surgical condi-
tions with TIVA for ESS. Additionally, we hypothesized
that many anesthesiology providers do not provide care for
ESS cases frequently, and may consider other factors greater
than the surgical field in choice of maintenance technique.
Materials and methods
Institutional Review Board (IRB) exemption was obtained
from the University of Texas Health Science Center San An-
tonio (IRB HSC20180291E), University of Michigan (IRB
HUM00150344), and Virginia Commonwealth University
(IRB HM20014737). An electronic questionnaire (Support-
ing Fig. 1) was developed by the research team. The initial
draft was piloted on a focus group composed of 5 anesthe-
siologists. Feedback was sought and the questionnaire was
further revised.
The following demographic parameters were collected:
training level, fellowship training in head and neck anesthe-
sia, number of ESS cases managed per month. Participants
were asked to provide their understanding of current med-
ical literature regarding use of TIVA for ESS. This survey
inquired about practice patterns for anesthetic techniques
in ESS, including methods to ensure unconsciousness and
which specific anesthetic agents are used. Participants’ sat-
isfaction with their training specific to ESS was assessed.
Additionally, anesthesiology faculty were asked their per-
ceived level of comfort with residents and CRNAs perform-
ing TIVA for ESS.
The survey tool was distributed via email to 719 par-
ticipants comprising of 179 anesthesiology residents, 272
faculty, and 268 CRNAs at multiple training programs be-
tween February 2019 and April 2019. There was no incen-
tive to participate in this survey. Individuals were able to
decline to participate in the survey or withdraw at any time.
Surveys were administered in electronic format via RED-
Cap electronic data capture tools hosted at the University
of Texas Health Science Center San Antonio and responses
were automatically recorded in a secure electronic database
without identifying information.13
Results
A total of 266 anesthesia providers responded to the survey.
Sixty-six responses were excluded based on incompleteness
and/or early termination of the survey. A total of 200 re-
sponses (28%) were included in the final analysis, com-
prising 51 residents, 2 fellows, 79 CRNAs, and 68 faculty
members.
Table 1 describes the demographics of the survey pop-
ulation. 90% of anesthesia providers managed fewer than
5 ESS cases per month. Sixty-five percent of participants re-
sponded that they were not familiar with current literature
and investigational findings on TIVA for ESS. When asked
to provide a general anesthetic for a patient undergoing ESS
with no relevant comorbidities, 81 (40%) participants se-
lected an inhalational anesthetic approach and 119 (60%)
chose TIVA.
When asked about ESS-specific anesthesia training, most
participants (73%) had received instruction via direct su-
pervision of attending physicians in the operating room,
whereas few had received in-person lectures or online
courses (19 and 11 respondents, respectively).
Residents, attending physicians, and CRNAs were sat-
isfied with their training for inhalational anesthetic man-
agement for ESS 56% and TIVA approach for ESS (57%).
Most residents stated that they were comfortable or very
comfortable with using inhalational anesthesia (74%) or
TIVA (79%) for ESS. However, residents (51%) and CR-
NAs (75%) responded that they would participate in addi-
tional training opportunities.
Thirty-one (80%) anesthesiology attending physicians re-
sponded that they were neutral or comfortable with first-
year clinical anesthesia (CA-1) residents performing TIVA
for ESS. As expected, the level of comfort increased as expe-
rience increased, with 64 (94%) attending physicians being
comfortable or very comfortable with third-year clinical
anesthesia (CA-3) residents performing TIVA for ESS.
Figure 1 details the rankings of specific considerations
when using TIVA for ESS. Postoperative nausea, intraop-
erative hemodynamics, and gentle emergence were the top
3 considerations for using TIVA. Least important consid-
erations were cost of anesthetic agents and surgical field
visibility.
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TABLE 1. Demographics of survey respondents
Faculty
Characteristic Resident CRNA Non-H&N H&N
Total surveyed (n) 179 268 272
Total number of respondents (n) 53 79 56 12
Year in residency (n)
CA-1 19 – – –
CA-2 19 – – –
CA-3 13 – – –
Fellow 2 – – –
How many years have you been practicing medicine? years (95% CI) 11.29 (9.72–13.88) 11.04 (8.53–13.55)
On average, how many ESS cases do you manage per month? n (%)
0–5 cases 52 (98) 69 (87) 54 (96) 4 (33)
5–10 cases 1 (2) 9 (11) 2 (4) 4 (33)
>10 cases 0 (0) 1 (1) 0 (0) 4 (33)
Out of these ESS cases, what percentage of cases do you use TIVA? n (%)
<50% 16 (30) 33 (42) 28 (50) 0 (0)
50%–75% 10 (19) 11 (14) 7 (13) 0 (0)
75%–90% 6 (11) 4 (5) 4 (7) 2 (17)
>90% 21 (40) 31 (39) 17 (30) 10 (83)
How would you rate the strength of evidence in the use of TIVA in ESS? n (%)
Not familiar with current literature 34 (64) 58 (73) 33 (59) 5 (42)
No articles support TIVA use in ESS 1 (2) 0 (0) 0 (0) 0 (0)
Few articles support TIVA use in ESS 8 (15) 11 (14) 15 (27) 5 (42)
Many articles support TIVA use in ESS 10 (19) 10 (13) 8 (14) 2 (17)
CA = clinical anesthesia; CI = confidence interval; ESS = endoscopic sinus surgery; H&N = specialize in head and neck anesthesiology; TIVA = total intravenous anesthesia.
Anesthesia practice patterns for TIVA are detailed in
Table 2.
Discussion
Previous comparative studies of inhalational anesthesia and
TIVA techniques for ESS have primarily focused on out-
comes of ESS such as blood loss and cardiovascular param-
eters, rather than the factors that influence decision making
to the choice of anesthetic.7,9,14 This survey is the first to
investigate the opinions of anesthesia providers at various
levels of training and geographic locations on inhalational
anesthesia and TIVA for ESS with regard to practice pat-
terns, recognition of clinical evidence, procedural comfort,
and training satisfaction. We found that many providers (1)
do not routinely manage high volumes of ESS cases, (2) are
unfamiliar with TIVA literature for ESS, and (3) are open
to further learning.
In this study, 65% of survey respondents stated that they
were not very familiar with the current literature on TIVA
for ESS. Thus, trainees might benefit from further education
specific to ESS. Many trainees were comfortable with per-
forming anesthesia for ESS, but were willing to participate
in additional training opportunities to learn techniques that
can benefit both surgeon and patient.
The most common method of TIVA training was the
traditional model of apprenticeship, where residents will
begin by assisting attending physicians and gradually build
the skills and experience necessary for independent practice.
However, this modality can be limited by low ESS case
volumes. For 98% of residents and 96% of non–head and
neck fellowship-trained faculty, ESS is not a part of their
routine weekly clinical practice because they are managing
fewer than 5 ESS cases a month. Thus, opportunities for
direct supervision in the operating room may be hampered
by the low numbers of ESS cases.
TIVA is used for many operations other than ESS for a va-
riety of reasons.15 This study suggests that the anesthesiol-
ogists’ main considerations for choosing when to use TIVA
are patient factors such as maintaining hemodynamics
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FIGURE 1. Ranking of considerations for use of TIVA in ESS. ESS = endoscopic sinus surgery; TIVA = total intravenous anesthesia.








When performing general anesthesia using TIVA, which of the following do you commonly use to ensure unconsciousness? Select all that apply
Bispectral index monitor 20 (37.7) 23 (33.8) 17 (21.5)
Minimum alveolar concentration values 27 (50.9) 23 (33.8) 33 (41.8)
Hemodynamics 27 (50.9) 38 (55.9) 48 (60.8)
Inhalational agent 47 (69.1) 40 (75.5) 48 (60.8)
Desflurane 7 (13.2) 3 (4.4) 2 (2.5)
Sevoflurane 21 (39.6) 21 (30.9) 25 (31.6)
Isoflurane 20 (37.7) 8 (11.8) 12 (15.2)
Nitrous oxide 18 (34.0) 25 (36.8) 26 (32.9)
Which of the following agents do you most commonly use for maintenance of TIVA? Select all that apply
Propofol 53 (100.0) 68 (100.0) 79 (100.0)
Remifentanil 53 (100.0) 63 (92.6) 70 (88.6)
Fentanyl 1 (1.9) 9 (13.2) 16 (20.3)
Dexmedetomidine 14 (26.4) 13 (19.1) 19 (24.1)
Lidocaine 8 (15.1) 10 (14.7) 8 (10.1)
Ketamine 12 (22.6) 12 (17.6) 21 (26.6)
Sufentanil 16 (30.2) 5 (7.4) 11 (13.9)
Alfentanil 1 (1.9) 0 (0.0) 0 (0.0)
CRNA = certified registered nurse anesthetist; ESS = endoscopic sinus surgery; TIVA = total intravenous anesthesia.
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and controlling postoperative nausea. These factors are
clearly important in patient care. However, our findings
suggest anesthesia providers are often less focused on the
surgical field during ESS, and therefore the surgeons should
engage their colleagues in an informed dialogue regarding
the desire and reasoning for TIVA in ESS. Unlike the 7%
rate reported by Suhitharan et al.,12 approximately 60%
of those surveyed at 3 large medical centers default to the
use of TIVA in ESS. The relatively lesser consideration of
surgical visualization suggests an opportunity to translate
the findings of the existing literature into routine practice,
paralleling previous studies that show a lack of awareness
and familiarity as barriers to guideline adherence.16
In terms of TIVA practices, this study showed that propo-
fol and remifentanil were the most commonly used mainte-
nance agents. The pharmacokinetic and pharmacodynam-
ics properties of propofol and newer short-acting opioids
have been well-studied and routinely used for TIVA. Unlike
inhalational anesthesia where exhaled volatile anesthetics
can be measured, there are no available methods to measure
serum drug concentrations in TIVA to ensure intraopera-
tive amnesia.17 Thus, there is a potential role for additional
monitoring such as bispectral index monitors if the anes-
thesia provider believes it is warranted, which one-third
of respondents use.18 Although not strictly TIVA, 68% of
respondents added a small amount of inhalational gas to
TIVA to ensure unconsciousness. Other efforts to address
the challenges of titrating TIVA include target controlled
infusion (TCI) systems. These devices automate TIVA de-
livery by calculation of an ideal drug infusion profile based
on a patient’s profile and target drug concentration.19 Al-
though TCI systems are well-established in Europe, it cur-
rently has not received regulatory approval in the United
States and is only used in research.19,20
There are several limitations of this study. First, although
the survey response rate (28%) is somewhat low, it is
comparable to other similar studies that used web-based
survey distribution methods.21 Further, the total number
of respondents (200) from multiple levels of experience
augments the generalizability of these findings. As indi-
viduals are more apt to respond to survey on topics that
are important or of interest to them, it is possible that
survey participants have greater ESS experience compared
to nonrespondents.22 Second, participants were recruited
from selected academic medical centers and may not gen-
eralize to other settings. However, disparate geographic
locations were chosen to ensure a broad range of practice
patterns and backgrounds. Per the results of the question-
naire, the majority of TIVA training for ESS was conducted
via faculty supervision in the operating room. Thus, anes-
thetic practice may vary based on resident education pro-
grams. Third, two-thirds of the respondents stated that they
add inhalational agent to TIVA for maintenance, which is
not described in the literature strictly comparing inhala-
tional anesthesia and TIVA. Nevertheless, our findings sup-
port the need for ongoing education specific to ESS anes-
thesia and for effective communication between surgeons
and their anesthesiologist colleagues regarding anesthetic
preferences.
Conclusion
Many anesthesiology providers in this unique survey of di-
verse training backgrounds were not aware of the literature
regarding the benefits of TIVA in ESS for surgical visual-
ization. TIVA is regularly performed for reasons other than
ESS, but in the case of ESS, anesthesiologists in this survey
frequently report reasons other than surgical field when
considering TIVA. Surgeons should be well versed in the
literature regarding TIVA and goals for their specific oper-
ation in order to engage in constructive conversations with
their anesthesiology colleagues.
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